LSE:AZNPharmaceuticals
Assessing AstraZeneca (LSE:AZN) Valuation After Strong Recent Share Price Momentum
Why AstraZeneca is on investors’ radar today
AstraZeneca (LSE:AZN) has drawn fresh attention after recent share price moves, with the stock up around 13% over the past month and about 8% over the past 3 months.
See our latest analysis for AstraZeneca.
That recent 13% 1 month share price return sits on top of a 1 year total shareholder return of about 31% and a 5 year total shareholder return close to 148%. This suggests momentum has been building over time rather than fading.
If AstraZeneca’s...